vspВопросы современной педиатрииCurrent Pediatrics1682-55271682-5535Издательство «ПедиатрЪ»10.15690/vsp.v15i6.1653vsp-1694Research ArticleОБЗОРЫ ЛИТЕРАТУРЫLITERATURE REVIEWТерапия острых респираторных инфекций у детей с позиции доказательной медициныEvidence-Based Treatment of Acute Respiratory Infections in ChildrenКондюринаЕ. Г.KondiurinaElena G.

Новосибирск, Российская Федерация

Novosibirsk, Russian Federation

https://orcid.org/0000-0003-0344-9412ЗеленскаяВ. В.ZelenskaiaVera V.

доктор медицинских наук, доцент, профессор кафедры педиатрии ФПКиППВ Новосибирского государственного медицинского университета Адрес: 630091, Новосибирск, Красный проспект, д. 52, тел.: +7 (3832) 229-10-83 

Novosibirsk, Russian Federation

v.zelenskaya@mail.ruНовосибирский государственный медицинский университетРоссияNovosibirsk State Medical UniversityRussian Federation201629122016156568575Copyright © Кондюрина Е.Г., Зеленская В.В., 20162016Кондюрина Е.Г., Зеленская В.В.Kondiurina E.G., Zelenskaia V.V.Данная работа распространяется под лицензией Creative Commons Attribution 4.0.This work is licensed under a Creative Commons Attribution 4.0 License.https://vsp.spr-journal.ru/jour/article/view/1694

Терапия острых респираторных инфекций (ОРИ) у детей остается важной задачей практического здравоохранения. В настоящее время проблема выбора лекарственных средств и полипрагмазия при ОРИ является весьма актуальной. В статье рассматриваются вопросы применения лекарственных средств при этиотропной и симптоматической терапии ОРИ у детей, особенности назначения муколитической терапии с позиций доказательной медицины.

Treatment of acute respiratory infections (ARI) in children is an important task of practical healthcare. Currently, the problem of choosing medicines and polypharmacy at ARI is very relevant. This article considers the issues of using medicines during a causal and symptomatic treatment of ARI in children, and peculiarities of the mucolytic evidence-based therapy order.

детиострые респираторные инфекциимуколитические препараты.childrenacute respiratory infectionsmucolytic agentsReferencesDorland’s illustrated medical dictionary. 27th ed. Philadelphia, Pa.: W. B. Saunders Co.; 1988.Dorland’s illustrated medical dictionary. 27th ed. Philadelphia, Pa.: W. B. Saunders Co.; 1988.О состоянии санитарно-эпидемиологического благополучия населения в Российской Федерации в 2015 году. Государственный доклад. — М.: Федеральная служба по надзору в сфере защиты прав потребителей и благополучия человека; 2016. — 200 с. [O sostoyanii sanitarno-epidemiologicheskogo blagopoluchiya naseleniya v Rossiiskoi Federatsii v 2015 godu. Gosudarstvennyi doklad. Moscow: Federal’naya sluzhba po nadzoru v sfere zashchity prav potrebitelei i blagopoluchiya cheloveka; 2016. 200 p. (In Russ).]О состоянии санитарно-эпидемиологического благополучия населения в Российской Федерации в 2015 году. Государственный доклад. — М.: Федеральная служба по надзору в сфере защиты прав потребителей и благополучия человека; 2016. — 200 с. [O sostoyanii sanitarno-epidemiologicheskogo blagopoluchiya naseleniya v Rossiiskoi Federatsii v 2015 godu. Gosudarstvennyi doklad. Moscow: Federal’naya sluzhba po nadzoru v sfere zashchity prav potrebitelei i blagopoluchiya cheloveka; 2016. 200 p. (In Russ).]Бокова Т.А. Острые респираторные вирусные инфекции у детей с отягощенным аллергологическим фоном: современные аспекты терапии // Лечащий врач. — 2016. — № 4 — С. 10–71. [Bokova TA. Ostrye respiratornye virusnye infektsii u detei s otyagoshchennym allergologicheskim fonom: sovremennye aspekty terapii. Practitioner. 2016;(4):10–71. (In Russ).]Бокова Т.А. Острые респираторные вирусные инфекции у детей с отягощенным аллергологическим фоном: современные аспекты терапии // Лечащий врач. — 2016. — № 4 — С. 10–71. [Bokova TA. Ostrye respiratornye virusnye infektsii u detei s otyagoshchennym allergologicheskim fonom: sovremennye aspekty terapii. Practitioner. 2016;(4):10–71. (In Russ).]Яцышина С.Б., Спичак Т.В., Ким С.С. и др. Выявление респираторных вирусов и атипичных бактерий у больных пневмонией и здоровых детей за десятилетний период наблюдения // Педиатрия. Журнал им. Г.Н. Сперанского. — 2016. — Т. 95. — № 2 — С. 43–50. [Yatsyshina SB, Spichak TV, Kim SS, et al. Revealing of respiratory viruses and atypical bacteria in children with pneumonia and healthy children for ten years of observation. Pediatriia. 2016;95(2):43–50. (In Russ).]Яцышина С.Б., Спичак Т.В., Ким С.С. и др. Выявление респираторных вирусов и атипичных бактерий у больных пневмонией и здоровых детей за десятилетний период наблюдения // Педиатрия. Журнал им. Г.Н. Сперанского. — 2016. — Т. 95. — № 2 — С. 43–50. [Yatsyshina SB, Spichak TV, Kim SS, et al. Revealing of respiratory viruses and atypical bacteria in children with pneumonia and healthy children for ten years of observation. Pediatriia. 2016;95(2):43–50. (In Russ).]Liu YC, Post JC. Biofilms in pediatric respiratory and related infections. Curr Allergy Asthma Rep. 2009;9(6):449–455. doi: 10.1007/s11882-009-0066-6.Liu YC, Post JC. Biofilms in pediatric respiratory and related infections. Curr Allergy Asthma Rep. 2009;9(6):449–455. doi: 10.1007/s11882-009-0066-6.Sanchez C, Mende K, Beckius M, et al. Biofilm formation by clinical isolates and the implications in chronic infections. BMC Infect Dis. 2013;13:47. doi: 10.1186/1471-2334-13-47.Sanchez C, Mende K, Beckius M, et al. Biofilm formation by clinical isolates and the implications in chronic infections. BMC Infect Dis. 2013;13:47. doi: 10.1186/1471-2334-13-47.Tikhomirova A, Kidd S. Haemophilus influenzae and Streptococcus pneumoniae: living together in a biofilm. Pathog Dis. 2013; 69(2):114–126. doi: 10.1111/2049-632X.12073.Tikhomirova A, Kidd S. Haemophilus influenzae and Streptococcus pneumoniae: living together in a biofilm. Pathog Dis. 2013; 69(2):114–126. doi: 10.1111/2049-632X.12073.Dalton T, Dowd S, Wolcott R, et al. An in vivo polymicrobial biofilm wound infection model to study interspecies interactions. PLoS One. 2011;6(11):e27317. doi: 10.1371/journal.pone.0027317.Dalton T, Dowd S, Wolcott R, et al. An in vivo polymicrobial biofilm wound infection model to study interspecies interactions. PLoS One. 2011;6(11):e27317. doi: 10.1371/journal.pone.0027317.Bjarnsholt T. The role of bacterial biofilms in chronic infections. APMIS. 2013;(136 Suppl):1–51. doi: 10.1111/apm.12099.Bjarnsholt T. The role of bacterial biofilms in chronic infections. APMIS. 2013;(136 Suppl):1–51. doi: 10.1111/apm.12099.Mietto C, Pinciroli R, Patel N, Berra L. Ventilator associated pneumonia: evolving definitions and preventive strategies. Respir Care. 2013;58(6):990–1007. doi: 10.4187/respcare.02380.Mietto C, Pinciroli R, Patel N, Berra L. Ventilator associated pneumonia: evolving definitions and preventive strategies. Respir Care. 2013;58(6):990–1007. doi: 10.4187/respcare.02380.Aslam S, Darouiche R. Role of antibiofilm-antimicrobial agents in controlling device- related infections. Int J Artif Organs. 2011; 34(9):752–758. doi: 10.5301/ijao.5000024.Aslam S, Darouiche R. Role of antibiofilm-antimicrobial agents in controlling device- related infections. Int J Artif Organs. 2011; 34(9):752–758. doi: 10.5301/ijao.5000024.Самсыгина Г.А. Современное лечение острых респираторных заболеваний у детей. Педиатрия. Журнал им. Г.Н. Сперанского. — 2013. — Т. 92. — № 3 — С. 38–42. [Samsygina GA. Sovremennoe lechenie ostrykh respiratornykh zabolevanii u detei. Pediatriia. 2013;92(3):38–42. (In Russ).]Самсыгина Г.А. Современное лечение острых респираторных заболеваний у детей. Педиатрия. Журнал им. Г.Н. Сперанского. — 2013. — Т. 92. — № 3 — С. 38–42. [Samsygina GA. Sovremennoe lechenie ostrykh respiratornykh zabolevanii u detei. Pediatriia. 2013;92(3):38–42. (In Russ).]Зайцева О.В., Зайцева С.В. Лечение и профилактика острых респираторных инфекций у часто болеющих детей // Лечащий врач. — 2008. — № 8 — С. 53–57. [Zaitseva OV, Zaitseva SV. Lechenie i profilaktika ostrykh respiratornykh infektsii u chasto boleyushchikh detei. Practitioner. 2008;(8):53–57. (In Russ).]Зайцева О.В., Зайцева С.В. Лечение и профилактика острых респираторных инфекций у часто болеющих детей // Лечащий врач. — 2008. — № 8 — С. 53–57. [Zaitseva OV, Zaitseva SV. Lechenie i profilaktika ostrykh respiratornykh infektsii u chasto boleyushchikh detei. Practitioner. 2008;(8):53–57. (In Russ).]Kobayashi H. Airway biofilms: implications for pathogenesis and therapy of respiratory tract infections. Treat Respir Med. 2005;4(4):241–253. doi: 10.2165/00151829-200504040- 00003.Kobayashi H. Airway biofilms: implications for pathogenesis and therapy of respiratory tract infections. Treat Respir Med. 2005;4(4):241–253. doi: 10.2165/00151829-200504040- 00003.Таточенко В.К. ОРВИ и грипп у детей. Основные трудности диагностики и возможности рациональной терапии // Лечащий врач. — 2015. — № 9 — С. 32–36. [Tatochenko VK. ORVI i gripp u detei. Osnovnye trudnosti diagnostiki i vozmozhnosti ratsional’noi terapii. Practitioner. 2015;(9):32–36. (In Russ).]Таточенко В.К. ОРВИ и грипп у детей. Основные трудности диагностики и возможности рациональной терапии // Лечащий врач. — 2015. — № 9 — С. 32–36. [Tatochenko VK. ORVI i gripp u detei. Osnovnye trudnosti diagnostiki i vozmozhnosti ratsional’noi terapii. Practitioner. 2015;(9):32–36. (In Russ).]Учайкин В.Ф., Нисевич Н.И., Шамшева О.В. Инфекционные болезни у детей. — М.: ГЭОТАР-Медиа; 2013. — 688 с. [Uchaikin VF, Nisevich NI, Shamsheva OV. Infektsionnye bolezni u detei. Moscow: GEOTAR-Media; 2013. 688 p. (In Russ).]Учайкин В.Ф., Нисевич Н.И., Шамшева О.В. Инфекционные болезни у детей. — М.: ГЭОТАР-Медиа; 2013. — 688 с. [Uchaikin VF, Nisevich NI, Shamsheva OV. Infektsionnye bolezni u detei. Moscow: GEOTAR-Media; 2013. 688 p. (In Russ).]Arroll B, Kenealy T. Antibiotics for the common cold and acute purulent rhinitis. Cochrane Database Syst Rev. 2005;(3):CD000247. doi: 10.1002/14651858.CD000247.pub2.Arroll B, Kenealy T. Antibiotics for the common cold and acute purulent rhinitis. Cochrane Database Syst Rev. 2005;(3):CD000247. doi: 10.1002/14651858.CD000247.pub2.Nyquist AC, Gonzales R, Steiner JF, Sande MA. Antibiotic prescribing for children with colds, upper respiratory infections, and bronchitis. JAMA. 1998;279(11):875–877. doi: 10.1001/jama.279.11.875.Nyquist AC, Gonzales R, Steiner JF, Sande MA. Antibiotic prescribing for children with colds, upper respiratory infections, and bronchitis. JAMA. 1998;279(11):875–877. doi: 10.1001/jama.279.11.875.Pennie R. Prospective study of antibiotic prescribing for children. Can Fam Physician. 1998;44:1850–1856.Pennie R. Prospective study of antibiotic prescribing for children. Can Fam Physician. 1998;44:1850–1856.Spurling GK, Del Mar CB, Dooley L, Foxlee R. Delayed antibiotics for respiratory infections. Cochrane Database Syst Rev. 2007;(3):CD004417. doi: 10.1002/14651858.CD004417.pub3.Spurling GK, Del Mar CB, Dooley L, Foxlee R. Delayed antibiotics for respiratory infections. Cochrane Database Syst Rev. 2007;(3):CD004417. doi: 10.1002/14651858.CD004417.pub3.Jefferson T, Jones MA, Doshi P, et al. Neuraminidase inhibitors for preventing and treating influenza in healthy adults and children. Cochrane Database Syst Rev. 2014; (4):CD008965. doi: 10.1002/14651858.CD008965.pub4.Jefferson T, Jones MA, Doshi P, et al. Neuraminidase inhibitors for preventing and treating influenza in healthy adults and children. Cochrane Database Syst Rev. 2014; (4):CD008965. doi: 10.1002/14651858.CD008965.pub4.Геппе Н.А., Теплякова Е.Д., Шульдяков А.А. и др. Инновации в педиатрии: оптимальный клинический эффект при лечении ОРВИ у детей препаратом комплексного действия // Педиатрия. Журнал им. Г.Н. Сперанского. — 2016. — Т. 95. — № 2 — С. 96–103. [Geppe NA, Teplyakova ED, Shuldyakov AA, et al. Innovations in pediatrics: the optimal clinical effec in acute respiratory viral infections treatment in children with complex action drug. Pediatriia. 2016;95(2):96–103. (In Russ).]Геппе Н.А., Теплякова Е.Д., Шульдяков А.А. и др. Инновации в педиатрии: оптимальный клинический эффект при лечении ОРВИ у детей препаратом комплексного действия // Педиатрия. Журнал им. Г.Н. Сперанского. — 2016. — Т. 95. — № 2 — С. 96–103. [Geppe NA, Teplyakova ED, Shuldyakov AA, et al. Innovations in pediatrics: the optimal clinical effec in acute respiratory viral infections treatment in children with complex action drug. Pediatriia. 2016;95(2):96–103. (In Russ).]Лихорадочные синдромы у детей: рекомендации по диагностике и лечению / Под общей ред. А.А. Баранова, В.К. Таточенко, М.Д. Бакрадзе. — М.: Союз педиатров России; 2011. — 228 с. [Likhoradochnye sindromy u detei: rekomendatsii po diagnostike i lecheniyu. Ed by Baranov A.A., Tatochenko V.K., Bakradze M.D. Moscow: Soyuz pediatrov Rossii; 2011. 228 p. (In Russ).]Лихорадочные синдромы у детей: рекомендации по диагностике и лечению / Под общей ред. А.А. Баранова, В.К. Таточенко, М.Д. Бакрадзе. — М.: Союз педиатров России; 2011. — 228 с. [Likhoradochnye sindromy u detei: rekomendatsii po diagnostike i lecheniyu. Ed by Baranov A.A., Tatochenko V.K., Bakradze M.D. Moscow: Soyuz pediatrov Rossii; 2011. 228 p. (In Russ).]Мелехина Е.В., Чугунова О.Я., Горелов А.В. и др. Тактика ведения детей с затяжным кашлем // Российский вестник перинатологии и педиатрии. — 2016. — № 1 — С. 110– 120. [Melekhina EV, Chugunova OL, Gorelov AV, et al. Management tactics for children with persistent cough. Rossiiskii vestnik perinatologii i pediatrii. 2016;61(1):110–120. (In Russ).]Мелехина Е.В., Чугунова О.Я., Горелов А.В. и др. Тактика ведения детей с затяжным кашлем // Российский вестник перинатологии и педиатрии. — 2016. — № 1 — С. 110– 120. [Melekhina EV, Chugunova OL, Gorelov AV, et al. Management tactics for children with persistent cough. Rossiiskii vestnik perinatologii i pediatrii. 2016;61(1):110–120. (In Russ).]De Sutter AIM, Saraswat A, van Driel ML. Antihistamines for the common cold. Cochrane Database Syst Rev. 2015;(11):CD009345. doi: 10.1002/14651858.CD009345.pub2.De Sutter AIM, Saraswat A, van Driel ML. Antihistamines for the common cold. Cochrane Database Syst Rev. 2015;(11):CD009345. doi: 10.1002/14651858.CD009345.pub2.Allan GM, Arroll B. Prevention and treatment of the common cold: making sense of the evidence. CMAJ. 2014;186(3):190–199. doi: 10.1503/cmaj.121442.Allan GM, Arroll B. Prevention and treatment of the common cold: making sense of the evidence. CMAJ. 2014;186(3):190–199. doi: 10.1503/cmaj.121442.Kim SY, Chang YJ, Cho HM, et al. Non-steroidal anti-inflammatory drugs for the common cold. Cochrane Database Syst Rev. 2015;(9):CD006362. doi: 10.1002/14651858.CD006362.pub4.Kim SY, Chang YJ, Cho HM, et al. Non-steroidal anti-inflammatory drugs for the common cold. Cochrane Database Syst Rev. 2015;(9):CD006362. doi: 10.1002/14651858.CD006362.pub4.Li S, Yue J, Dong BR, et al. Acetaminophen (paracetamol) for the common cold in adults. Cochrane Database Syst Rev. 2013;(7):CD008800. doi: 10.1002/14651858.CD008800.pub2.Li S, Yue J, Dong BR, et al. Acetaminophen (paracetamol) for the common cold in adults. Cochrane Database Syst Rev. 2013;(7):CD008800. doi: 10.1002/14651858.CD008800.pub2.Picon PD, Costa MB, da Veiga Picon R, et al. Symptomatic treatment of the common cold with a fixed-dose combination of paracetamol, chlorphenamine and phenylephrine: a randomized, placebo-controlled trial. BMC Infect Dis. 2013;13:556. doi: 10.1186/1471-2334- 13-556.Picon PD, Costa MB, da Veiga Picon R, et al. Symptomatic treatment of the common cold with a fixed-dose combination of paracetamol, chlorphenamine and phenylephrine: a randomized, placebo-controlled trial. BMC Infect Dis. 2013;13:556. doi: 10.1186/1471-2334- 13-556.Deckx L, De Sutter AIM, Guo L, et al. Nasal decongestants in monotherapy for the common cold. Cochrane Database Syst Rev. 2016;(10):CD009612. doi: 10.1002/14651858.CD009612.pub2.Deckx L, De Sutter AIM, Guo L, et al. Nasal decongestants in monotherapy for the common cold. Cochrane Database Syst Rev. 2016;(10):CD009612. doi: 10.1002/14651858.CD009612.pub2.Hayward G, Thompson MJ, Perera R, et al. Corticosteroids for the common cold. Cochrane Database Syst Rev. 2015;(10):CD008116. doi: 10.1002/14651858.CD008116.pub3.Hayward G, Thompson MJ, Perera R, et al. Corticosteroids for the common cold. Cochrane Database Syst Rev. 2015;(10):CD008116. doi: 10.1002/14651858.CD008116.pub3.Hemila H. Thomas Chalmers, vitamin C and the common cold. J R Soc Med. 2016;109(2):46. doi: 10.1177/0141076815606279.Hemila H. Thomas Chalmers, vitamin C and the common cold. J R Soc Med. 2016;109(2):46. doi: 10.1177/0141076815606279.Hemila H, Chalker E. Vitamin C for preventing and treating the common cold. Cochrane Database Syst Rev. 2013;(1):CD000980. doi: 10.1002/14651858.CD000980.pub4.Hemila H, Chalker E. Vitamin C for preventing and treating the common cold. Cochrane Database Syst Rev. 2013;(1):CD000980. doi: 10.1002/14651858.CD000980.pub4.Goldman RD. Treating cough and cold: Guidance for caregivers of children and youth. Paediatr Child Health. 2011;16(9):564–566.Goldman RD. Treating cough and cold: Guidance for caregivers of children and youth. Paediatr Child Health. 2011;16(9):564–566.Shields MD, Thavagnanam S. The difficult coughing child: prolonged acute cough in children. Cough. 2013;9:11. doi: 10.1186/1745-9974-9-11.Shields MD, Thavagnanam S. The difficult coughing child: prolonged acute cough in children. Cough. 2013;9:11. doi: 10.1186/1745-9974-9-11.Singh M, Singh M. Heated, humidified air for the common cold. Cochrane Database Syst Rev. 2013;(6):CD001728. doi: 10.1002/14651858.CD001728.pub5.Singh M, Singh M. Heated, humidified air for the common cold. Cochrane Database Syst Rev. 2013;(6):CD001728. doi: 10.1002/14651858.CD001728.pub5.Oduwole O, Meremikwu MM, Oyo-Ita A, Udoh EE. Honey for acute cough in children. Cochrane Database Syst Rev. 2014; (12):CD007094. doi: 10.1002/14651858.CD007094.pub4.Oduwole O, Meremikwu MM, Oyo-Ita A, Udoh EE. Honey for acute cough in children. Cochrane Database Syst Rev. 2014; (12):CD007094. doi: 10.1002/14651858.CD007094.pub4.Smith SM, Schroeder K, Fahey T. Over-the-counter (OTC) medications for acute cough in children and adults in community settings. Cochrane Database Syst Rev. 2014; (11):CD001831. doi: 10.1002/14651858.CD001831.pub5.Smith SM, Schroeder K, Fahey T. Over-the-counter (OTC) medications for acute cough in children and adults in community settings. Cochrane Database Syst Rev. 2014; (11):CD001831. doi: 10.1002/14651858.CD001831.pub5.Краснова Е.И., Проворова В.В., Гайнц О.В., Панасенко Л.М. Кашель у детей с острой респираторной инфекцией: когда назначать муколитики? // Лечащий врач. — 2015. — № 9 — С. 42–46. [Krasnova EI, Provorova VV, Gaints OV, Panasenko LM. Kashel’ u detei s ostroi respiratornoi infektsiei: kogda naznachat’ mukolitiki? Practitioner. 2015;(9):42–46. (In Russ).]Краснова Е.И., Проворова В.В., Гайнц О.В., Панасенко Л.М. Кашель у детей с острой респираторной инфекцией: когда назначать муколитики? // Лечащий врач. — 2015. — № 9 — С. 42–46. [Krasnova EI, Provorova VV, Gaints OV, Panasenko LM. Kashel’ u detei s ostroi respiratornoi infektsiei: kogda naznachat’ mukolitiki? Practitioner. 2015;(9):42–46. (In Russ).]Зайцева О.В., Зайцева С.В., Локшина Э.Э. Особенности терапии кашля у детей // Вопросы практической педиатрии. — 2015. — № 1 — С. 68–74. [Zaytseva OV, Zaytseva SV, Lokshina EE. Specificities of cough therapy in children. Problems of practical pediatrics. 2015;10(1):68–74. (In Russ).]Зайцева О.В., Зайцева С.В., Локшина Э.Э. Особенности терапии кашля у детей // Вопросы практической педиатрии. — 2015. — № 1 — С. 68–74. [Zaytseva OV, Zaytseva SV, Lokshina EE. Specificities of cough therapy in children. Problems of practical pediatrics. 2015;10(1):68–74. (In Russ).]Геппе Н.А., Снегоцкая М.Н., Пенкина М.В. Алгоритм лечения кашля у детей // Фарматека. — 2014. — № 1 — С. 71–75. [Geppe NA, Snegotskaya MN, Penkina MV. Algoritm lecheniya kashlya u detei. Farmateka. 2014;(1):71–75. (In Russ).]Геппе Н.А., Снегоцкая М.Н., Пенкина М.В. Алгоритм лечения кашля у детей // Фарматека. — 2014. — № 1 — С. 71–75. [Geppe NA, Snegotskaya MN, Penkina MV. Algoritm lecheniya kashlya u detei. Farmateka. 2014;(1):71–75. (In Russ).]Riise GC, Qvarfordt I, Larsson S, et al. Inhibitory effect of N-acetylcysteine on adherence of Streptococcus pneumoniae and Haemophilus influenzae to human oropharyngeal epithelial cells in vitro. Respiration. 2000;67(5):552–558. doi: 10.1159/000067473.Riise GC, Qvarfordt I, Larsson S, et al. Inhibitory effect of N-acetylcysteine on adherence of Streptococcus pneumoniae and Haemophilus influenzae to human oropharyngeal epithelial cells in vitro. Respiration. 2000;67(5):552–558. doi: 10.1159/000067473.Schwandt LQ, Van Weissenbruch R, Stokroos I, et al. Prevention of biofilm formation by dairy products and N-acetylcysteine on voice prostheses in an artificial throat. Acta Otolaryngol. 2004; 124(6):726–731. doi: 10.1080/00016480410022516.Schwandt LQ, Van Weissenbruch R, Stokroos I, et al. Prevention of biofilm formation by dairy products and N-acetylcysteine on voice prostheses in an artificial throat. Acta Otolaryngol. 2004; 124(6):726–731. doi: 10.1080/00016480410022516.Zhao T, Liu Y. N-acetylcysteine inhibit biofilms produced by Pseudomonas aeruginosa. BMC Microbiol. 2010;10:140. doi: 10.1186/1471-2180-10-140.Zhao T, Liu Y. N-acetylcysteine inhibit biofilms produced by Pseudomonas aeruginosa. BMC Microbiol. 2010;10:140. doi: 10.1186/1471-2180-10-140.Pintucci JP, Corno S, Garotta M. Biofilms and infections of the upper respiratory tract. Eur Rev Med Pharmacol Sci. 2010;14(8):683–690.Pintucci JP, Corno S, Garotta M. Biofilms and infections of the upper respiratory tract. Eur Rev Med Pharmacol Sci. 2010;14(8):683–690.Marchese A, Bozzolasco M, Gualco L, et al. Effect of fosfomycin alone and in combination with N-acetylcysteine on E. coli biofilms. Int J Antimicrob Agents. 2003;22 Suppl 2:95–100. doi: 10.1016/S0924-8579(03)00232-2.Marchese A, Bozzolasco M, Gualco L, et al. Effect of fosfomycin alone and in combination with N-acetylcysteine on E. coli biofilms. Int J Antimicrob Agents. 2003;22 Suppl 2:95–100. doi: 10.1016/S0924-8579(03)00232-2.El-Feky MA, El-Rehewy MS, Hassan MA, et al. Effect of ciprofloxacin and N- acetylcysteine on bacterial adherence and biofilm formation on ureteral stent surfaces. Pol J Microbiol. 2009;58(3):261–267.El-Feky MA, El-Rehewy MS, Hassan MA, et al. Effect of ciprofloxacin and N- acetylcysteine on bacterial adherence and biofilm formation on ureteral stent surfaces. Pol J Microbiol. 2009;58(3):261–267.Macchi A, Ardito F, Marchese A, et al. Efficacy of N-acetylcisteine in combination with thiamphenicol in sequential (intramuscular/aerosol) therapy of upper respiratory tract infections even if sustained by bacterial biofilms. J Chemother. 2006;18(5):507–513. doi: 10.1179/joc.2006.18.5.507.Macchi A, Ardito F, Marchese A, et al. Efficacy of N-acetylcisteine in combination with thiamphenicol in sequential (intramuscular/aerosol) therapy of upper respiratory tract infections even if sustained by bacterial biofilms. J Chemother. 2006;18(5):507–513. doi: 10.1179/joc.2006.18.5.507.Leite B, Gomes F, Teixeira P, et al. Staphylococcus epidermidis biofilms control by N- acetylcysteine and rifampicin. Am J Ther. 2013;20(4):322–328. doi: 10.1097/MJT.0b013e318209e17b.Leite B, Gomes F, Teixeira P, et al. Staphylococcus epidermidis biofilms control by N- acetylcysteine and rifampicin. Am J Ther. 2013;20(4):322–328. doi: 10.1097/MJT.0b013e318209e17b.Leite B, Gomes F, Teixeira P, et al. Combined effect of linezolid and N-acetylcysteine against Staphylococcus epidermidis biofilms. Enferm Infecc Microbiol Clin. 2013;31(10):655–659. doi: 10.1016/j.eimc.2012.11.011.Leite B, Gomes F, Teixeira P, et al. Combined effect of linezolid and N-acetylcysteine against Staphylococcus epidermidis biofilms. Enferm Infecc Microbiol Clin. 2013;31(10):655–659. doi: 10.1016/j.eimc.2012.11.011.Choe WT, Murray MT, Stidham KR, Roberson JB. N-Acetylcysteine as an adjunct for refractory ear infections. Otol Neurotol. 2007;28(8):1022–1025. doi: 10.1097/MAO.0b013e318155a4d3.Choe WT, Murray MT, Stidham KR, Roberson JB. N-Acetylcysteine as an adjunct for refractory ear infections. Otol Neurotol. 2007;28(8):1022–1025. doi: 10.1097/MAO.0b013e318155a4d3.Chalumeau M, Duijvestijn YCM. Acetylcysteine and carbocysteine for acute upper and lower respiratory tract infections in paediatric patients without chronic broncho-pulmonary disease. Cochrane Database Syst Rev. 2013(5):CD003124. doi: 10.1002/14651858.CD003124.pub4.Chalumeau M, Duijvestijn YCM. Acetylcysteine and carbocysteine for acute upper and lower respiratory tract infections in paediatric patients without chronic broncho-pulmonary disease. Cochrane Database Syst Rev. 2013(5):CD003124. doi: 10.1002/14651858.CD003124.pub4.Baiardi P, Ceci A, Felisi M, et al. In-label and off-label use of respiratory drugs in the Italian paediatric population. Acta Paediatr. 2010;99(4):544–549. doi: 10.1111/j.1651- 2227.2009.01668.x.Baiardi P, Ceci A, Felisi M, et al. In-label and off-label use of respiratory drugs in the Italian paediatric population. Acta Paediatr. 2010;99(4):544–549. doi: 10.1111/j.1651- 2227.2009.01668.x.Zuidgeest MG, van Dijk L, Smit HA, et al. Prescription of respiratory medication without an asthma diagnosis in children: a population based study. BMC Health Serv Res. 2008;8:16. doi: 10.1186/1472-6963-8-16.Zuidgeest MG, van Dijk L, Smit HA, et al. Prescription of respiratory medication without an asthma diagnosis in children: a population based study. BMC Health Serv Res. 2008;8:16. doi: 10.1186/1472-6963-8-16.Bianchi M, Clavenna A, Sequi M, et al. Spirometry testing in a popu lation of Italian children: age and gender differences. Respir Med. 2012;106(10):1383–1388. doi: 10.1016/j.rmed.2012.06.005.Bianchi M, Clavenna A, Sequi M, et al. Spirometry testing in a popu lation of Italian children: age and gender differences. Respir Med. 2012;106(10):1383–1388. doi: 10.1016/j.rmed.2012.06.005.Conroy S. Association between licence status and medication errors. Arch Dis Child. 2011;96(3):305–306. doi: 10.1136/adc.2010.191940.Conroy S. Association between licence status and medication errors. Arch Dis Child. 2011;96(3):305–306. doi: 10.1136/adc.2010.191940.

The authors declare that there are no conflicts of interest present.